Biotech

All Articles

Turnstone gives up 60%, shocks C-suite to extend cash

.Turnstone Biologics is reducing its own headcount by 60% and shocking its own C-suite in order to a...

Gilead gives up on $15M MASH wager after weighing preclinical records

.In a year that has found an approval and also a plethora of readouts for metabolic dysfunction-asso...

Texas biotech centers cancer cells deal, pins hopes on weight problems

.Alaunos Therapies is actually axing a contract with Precigen, losing hope licensing liberties to an...

Capricor reveals much more records for DMD treatment after launching BLA

.Capricor Therapies is actually taking a victory lap for their phase 2 Duchenne muscular dystrophy (...

FDA locations Kezar lupus trial in grip observing 4 person deaths

.The FDA has actually positioned Kezar Life Sciences' lupus test on grip after the biotech flagged f...

Phase 3 Academic Rock test attacks SMA goal, sending out stock up 200%

.A phase 3 test of Academic Rock's vertebral muscle degeneration (SMA) applicant has actually struck...

CAMP 4 is most current to eye IPO, while Upstream describe $182M plan

.RNA biotech CAMP4 Therapeutics has marked out prepare for a $67 thousand IPO, along with inflammati...

Galecto purchases leukemia medicine, loses bone tissue cancer resource in pivot

.A year after the failing of an idiopathic pulmonary fibrosis prospect sent out Galecto on a hunt fo...

Judo throws down $100M to knock out renal disease

.Taking the mat is Judo Bio, a promising biotech armed with $100 million to cultivate oligonucleotid...

AstraZeneca spends CSPC $100M for preclinical heart problem drug

.AstraZeneca has paid CSPC Pharmaceutical Team $100 thousand for a preclinical heart disease medicat...